Protara Therapeutics (TARA) Financials: Revenue & Earnings

TARA price $2.44 -0.04 -1.42%

Ticker
TARA
Price
$2.44
Change
-0.04 -1.42%
Market cap ?
$143.90M
P/E ?
-1.71
Forward P/E ?
14.76
Dividend yield ?
0.00%
Beta ?
1.47
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
0000000000

Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigational cellular therapy currently under evaluation for the treatment of…

Fair value

TARA fair value $6.45. Price $2.44. Price is 62% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare TARA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.37——
2026-08-11-0.36-0.33——
2026-05-13-0.31-0.36——
2026-03-10-0.37-0.32——
2025-11-10-0.31-0.39——
2025-08-11-0.35-0.43——
2025-05-08-0.29-0.47——
2025-03-05-0.48-0.57——
2024-11-12-0.50-0.50——
2024-08-06-0.45-0.82——
2024-05-02-0.97-0.99——
2024-03-13-0.90-1.031.21M—
2023-11-03-0.87-1.10——
2023-08-03-1.00-0.97——
2023-05-04-0.80-1.00——
2023-03-08-0.84-0.77——
2022-11-03-0.68-0.85——
2022-08-09-0.80-1.13——
2022-05-05-0.96-1.09——
2022-03-09-0.91-0.94——
2021-11-04-0.96-1.15——
2021-08-05-1.14-1.14——
2021-05-06-1.20-0.92——
2021-03-11-0.79-0.42——
2020-11-12-1.26-0.62——
2020-07-31-1.22-0.46——
2020-05-13-1.81-0.41——
2020-03-20-2.55-0.71——
2019-10-31-3.20-3.60——
2019-08-07-10.80-6.80——
2019-05-08-13.60-9.00——
2019-03-13-10.80-10.20——
2018-11-07-10.00-12.00——
2018-08-07-11.20-14.20——
2018-05-09-13.60-13.84——
2018-03-14-12.40-16.80——
2017-11-07-28.00-15.53——
2017-08-07-13.20-17.20——
2017-05-10-15.60-16.70——
2017-03-16-16.80-18.30——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-30Shefferman JesseSell14.00K——
2026-06-30Shefferman JesseSell7.00K——
2026-06-30Shefferman JesseSell4.00K——
2026-06-30Shefferman JesseSell5.00K——
2026-06-29Shefferman JesseBuy215.69K$1.91411.96K
2026-06-29Shefferman JesseSell215.69K$4.09882.16K
2026-06-29Shefferman JesseSell215.69K$1.91411.96K
2026-06-15Levy Richard SBuy31.00K$3.94122.14K
2026-06-15Solomon Michael EdwardBuy31.00K$3.94122.14K
2026-06-15Smith CynthiaBuy31.00K$3.94122.14K
2026-06-15SARGEN GREGORYBuy31.00K$3.94122.14K
2026-06-15Huang JaneBuy31.00K$3.94122.14K
2026-06-15GARCEAU ROGERBuy31.00K$3.94122.14K
2026-06-15Flannelly Barry PBuy31.00K$3.94122.14K
2026-06-15BESHAR LUKE MBuy31.00K$3.94122.14K
2026-04-08Zummo JacquelineSell1.13K$5.406.12K
2026-04-01Zummo JacquelineSell22.60K$5.26118.87K
2026-01-26Fry HannahSell1.46K$6.679.72K
2026-01-26Fabbio PatrickSell3.26K$6.6721.75K
2026-01-26Shefferman JesseSell8.73K$6.6758.24K
2026-01-26Zummo JacquelineSell3.72K$6.6724.84K
2026-01-20Shefferman JesseSell16.32K$5.6091.40K
2026-01-20Fabbio PatrickSell3.06K$5.6017.15K
2026-01-20Zummo JacquelineSell6.58K$5.6036.84K
2026-01-20Fry HannahSell2.13K$5.6011.94K
2026-01-16CONKLING WILLIAMBuy158.00K$5.01791.58K
2026-01-16CONKLING WILLIAMBuy26.00K——
2026-01-16Fabbio PatrickBuy175.00K$5.01876.75K
2026-01-16Fabbio PatrickBuy28.00K——
2026-01-16Fry HannahBuy55.00K$5.01275.55K
2026-01-16Fry HannahBuy9.50K——
2026-01-16Nicacio Leonardo VianaBuy158.00K$5.01791.58K
2026-01-16Nicacio Leonardo VianaBuy26.00K——
2026-01-16Shefferman JesseBuy87.00K——
2026-01-16Shefferman JesseBuy524.00K$5.012.63M
2026-01-16Zummo JacquelineBuy180.00K$5.01901.80K
2026-01-16Zummo JacquelineBuy30.00K——
2025-06-27Shefferman JesseSell10.20K——
2025-06-27Shefferman JesseSell3.37K——
2025-06-26Shefferman JesseSell1.70K——
2025-06-26Shefferman JesseSell3.40K——
2025-06-24Shefferman JesseSell300.00K——
2025-06-12SARGEN GREGORYBuy24.00K$3.2678.24K
2025-06-12Levy Richard SBuy24.00K$3.2678.24K
2025-06-12Solomon Michael EdwardBuy24.00K$3.2678.24K
2025-06-12Huang JaneBuy24.00K$3.2678.24K
2025-06-12Smith CynthiaBuy24.00K$3.2678.24K
2025-06-12GARCEAU ROGERBuy24.00K$3.2678.24K
2025-06-12Flannelly Barry PBuy24.00K$3.2678.24K
2025-06-12BESHAR LUKE MBuy24.00K$3.2678.24K
2025-06-02CONKLING WILLIAMBuy200.00K$3.30660.00K
2025-06-02CONKLING WILLIAMBuy50.00K——
2025-06-02CONKLING WILLIAMOther0——
2025-05-14Levy Richard SBuy20.00K$3.1963.80K
2025-04-15Nicacio Leonardo VianaBuy150.00K$4.17625.50K
2025-04-15Nicacio Leonardo VianaBuy50.00K——
2025-04-15Nicacio Leonardo VianaOther0——
2025-03-26Zummo JacquelineSell21.22K$4.5396.14K
2025-01-24Fabbio PatrickOther0——
2025-01-24Shefferman JesseOther0——
2025-01-24Fry HannahOther0——
2025-01-24Zummo JacquelineOther0——
2025-01-24Shefferman JesseBuy65.00K——
2025-01-24Shefferman JesseBuy387.00K$4.531.75M
2025-01-24Zummo JacquelineBuy146.00K$4.53661.38K
2025-01-24Zummo JacquelineBuy24.50K——
2025-01-24Fry HannahBuy55.00K$4.53249.15K
2025-01-24Fry HannahBuy9.50K——
2025-01-24Fabbio PatrickBuy140.00K$4.53634.20K
2025-01-24Fabbio PatrickBuy23.50K——
2025-01-21Shefferman JesseSell15.47K$4.7673.63K
2025-01-21Fabbio PatrickSell3.06K$4.7614.57K
2025-01-21Fry HannahSell2.13K$4.7610.14K
2025-01-21Zummo JacquelineSell6.55K$4.7631.20K
2025-01-03Shefferman JesseSell6.48K$6.1439.78K
2025-01-03Zummo JacquelineSell2.16K$6.1413.24K
2025-01-03Fry HannahSell394$6.142.42K
2024-09-12Opaleye Management Inc.Sell119.80K$1.71204.73K
2024-09-12Opaleye Management Inc.Sell6.50K$1.7111.11K
2024-09-11Opaleye Management Inc.Sell31.00K$1.7153.14K
2024-09-11Opaleye Management Inc.Sell1.60K$1.712.74K
2024-09-10Opaleye Management Inc.Sell24.00K$1.7742.46K
2024-09-10Opaleye Management Inc.Sell1.50K$1.772.65K
2024-09-09Opaleye Management Inc.Sell34.59K$1.8965.54K
2024-09-09Opaleye Management Inc.Sell1.90K$1.893.60K
2024-08-28Shefferman JesseSell5.26K——
2024-08-28Shefferman JesseSell3.30K——
2024-07-16Opaleye Management Inc.Sell7.90K$2.4419.28K
2024-07-16Opaleye Management Inc.Sell3.50K$2.448.55K
2024-07-11Opaleye Management Inc.Sell32.99K$2.4079.30K
2024-07-11Opaleye Management Inc.Sell15.00K$2.4036.05K
2024-07-10Opaleye Management Inc.Sell13.06K$2.3130.14K
2024-07-10Opaleye Management Inc.Sell5.00K$2.3111.54K
2024-07-09Opaleye Management Inc.Sell6.00K$2.2113.28K
2024-07-09Opaleye Management Inc.Sell2.50K$2.215.53K
2024-07-01Opaleye Management Inc.Sell5.79K$2.1212.29K
2024-07-01Opaleye Management Inc.Sell2.50K$2.125.31K
2024-06-28Opaleye Management Inc.Sell12.99K$2.0726.96K
2024-06-28Opaleye Management Inc.Sell5.00K$2.0710.37K
2024-06-27Opaleye Management Inc.Sell34.10K$2.2677.01K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 123, holders +5 vs prior quarter. Ownership 75.79%.

HolderSharesChangeChange %Value
JUPITER TOPCO LLC4.70M4.70MNew17.92M
BLACKROCK, INC.3.66M268.53K+7.91%13.99M
MILLENNIUM MANAGEMENT LLC3.10M269.96K+9.54%11.85M
VELAN CAPITAL INVESTMENT MANAGEMENT LP2.84M10.00K+0.35%10.87M
VANGUARD CAPITAL MANAGEMENT LLC2.30M181.12K+8.55%8.79M
BLACKSTONE INC.2.27M00.00%8.65M
ORBIMED ADVISORS LLC2.22M2.22MNew8.48M
SIO CAPITAL MANAGEMENT, LLC1.92M-47.97K-2.44%7.34M
ACORN CAPITAL ADVISORS, LLC1.75M00.00%6.69M
INTEGRAL HEALTH ASSET MANAGEMENT, LLC1.50M-250.00K-14.29%5.73M
5AM VENTURE MANAGEMENT, LLC1.37M00.00%5.23M
GEODE CAPITAL MANAGEMENT, LLC1.33M149.05K+12.66%5.07M
CITADEL ADVISORS LLC1.23M1.22M+8702.61%4.71M
STATE STREET CORP1.07M63.15K+6.28%4.08M
QUBE RESEARCH & TECHNOLOGIES LTD1.05M868.51K+490.67%3.99M
BALYASNY ASSET MANAGEMENT L.P.1.03M1.03MNew3.92M
BAKER BROS. ADVISORS LP971.61K00.00%3.71M
ADAR1 CAPITAL MANAGEMENT, LLC940.51K00.00%3.59M
BANK OF AMERICA CORP /DE/882.18K-43.74K-4.72%3.37M
MARSHALL WACE, LLP701.02K650.29K+1281.84%2.68M
DIMENSIONAL FUND ADVISORS LP683.23K151.96K+28.60%2.61M
NORTHERN TRUST CORP552.31K177.45K+47.34%2.11M
POINT72 ASSET MANAGEMENT, L.P.548.93K-603.78K-52.38%2.10M
GOLDMAN SACHS GROUP INC546.23K148.25K+37.25%2.09M
CATALIO CAPITAL MANAGEMENT, LP520.15K-59.88K-10.32%1.99M

Earnings and financials

Protara Therapeutics, Inc. (TARA) trades at $2.44, with a market cap of $143.90M and a trailing P/E of -1.71. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
0000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Protara Therapeutics (TARA) Financials: Revenue & Earnings

TARA$2.44-0.04 -1.42%

$143.90M

Market Cap

-1.71

P/E

14.76

Forward P/E

—

Score

Price History